Jim Simons Tff Pharmaceuticals, Inc. Transaction History

Renaissance Technologies LLC

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	BUY	$0.31 - $0.48 $17,050 - $26,400	55,000 Added 54.73%	155,500 $54,000
Q2 2023 Aug 11, 2023	BUY	$0.43 - $0.77 $7,697 - $13,784	17,902 Added 21.67%	100,500 $47,000
Q1 2023 May 12, 2023	BUY	$0.62 - $1.1 $6,474 - $11,487	10,443 Added 14.47%	82,598 $57,000
Q4 2022 Feb 13, 2023	BUY	$0.84 - $100.75 $60,610 - $7.27 Million	72,155 New	72,155 $76,000
Q4 2021 Feb 11, 2022	SELL	$6.86 - $9.65 $596,820 - $839,550	-87,000 Closed	0 $0
Q3 2021 Nov 12, 2021	SELL	$7.21 - $10.49 $689,997 - $1 Million	-95,700 Reduced 52.38%	87,000 $672,000
Q2 2021 Aug 13, 2021	BUY	$8.48 - $13.61 $1 Million - $1.61 Million	118,000 Added 182.38%	182,700 $1.76 Million
Q1 2021 May 13, 2021	BUY	$12.96 - $19.75 $384,989 - $586,693	29,706 Added 84.89%	64,700 $878,000
Q4 2020 Feb 10, 2021	SELL	$12.74 - $18.49 $925,000 - $1.34 Million	-72,606 Reduced 67.48%	34,994 $501,000
Q3 2020 Nov 13, 2020	SELL	$5.86 - $18.47 $161,571 - $509,254	-27,572 Reduced 20.4%	107,600 $1.99 Million
Q2 2020 Aug 13, 2020	BUY	$3.79 - $6.08 $512,301 - $821,845	135,172 New	135,172 $779,000

Ticker TFFP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 25,477,800
Market Cap $1.53M
Description
TFF Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, focuses on developing and commercializing drug products based on its patented Thin Film Freezing (TFF) technology platform in the United States and Australia. It intends to focus on the development of inhaled dry powder drugs for the treatment of pulmonary diseases and condit...

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.